BIOLASE, Inc. provided earnings guidance for the Full-Year 2023. For the period, the company's full-year 2023 revenue is expected to be in the range of $48.9 million to $49.2 million, achieving 1% growth over 2022 despite the industry headwinds and interest rate environment.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.169 USD | +0.60% | +13.28% | -85.03% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.03% | 5.59M | |
+7.93% | 219B | |
+7.53% | 184B | |
+15.20% | 138B | |
-1.03% | 62.54B | |
+7.23% | 52.22B | |
+12.58% | 51.73B | |
+1.61% | 41.4B | |
+5.32% | 37.17B | |
+25.66% | 31.76B |
- Stock Market
- Equities
- BIOL Stock
- News BIOLASE, Inc.
- BIOLASE, Inc. Provides Earnings Guidance for the Full-Year 2023